| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $627K | — |
| R&D Expense | $0 | — |
| SG&A Expense | $16.9M | +1527.5% |
| Operating Income | -$19.0M | -648.4% |
| Interest Expense | $428K | -86.8% |
| Pre-tax Income | -$18.9M | -232.9% |
| Income Tax | -$36K | — |
| Net Income | -$18.9M | -232.7% |
| EPS (Basic) | -$0.45 | -186.5% |
| EPS (Diluted) | -$0.45 | -200.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $193K | — |
| Accounts Receivable | $193K | — |
| Current Assets | $472K | +2283.9% |
| Total Assets | $8.4M | +33.7% |
| Current Liabilities | $9.9M | -32.9% |
| Total Liabilities | $10.1M | -38.1% |
| Stockholders' Equity | -$1.7M | +83.4% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$336K | +1.5% |
| Capital Expenditures | $23K | — |
| Investing Cash Flow | $10K | +107.6% |
| Financing Cash Flow | $521K | +11.1% |
| Free Cash Flow | -$359K | -5.3% |